Total Payments
$27,171
2024 Payments
$3,124
Companies
65
Transactions
1,963
Medicare Patients
8,684
Medicare Billing
$929,914
Payment Breakdown by Category
Food & Beverage$26,762 (98.5%)
Education$409.44 (1.5%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $26,762 | 1,938 | 98.5% |
| Education | $409.44 | 25 | 1.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $3,935 | 223 | $0 (2024) |
| ABBVIE INC. | $2,375 | 205 | $0 (2024) |
| Novo Nordisk Inc | $1,695 | 120 | $0 (2024) |
| Lilly USA, LLC | $1,670 | 114 | $0 (2024) |
| Amgen Inc. | $1,508 | 125 | $0 (2024) |
| GlaxoSmithKline, LLC. | $1,490 | 108 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,232 | 91 | $0 (2024) |
| PFIZER INC. | $913.35 | 82 | $0 (2024) |
| Amarin Pharma Inc. | $888.03 | 74 | $0 (2023) |
| SCILEX PHARMACEUTICALS INC. | $879.12 | 65 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,124 | 205 | AstraZeneca Pharmaceuticals LP ($618.19) |
| 2023 | $3,931 | 283 | ABBVIE INC. ($638.48) |
| 2022 | $4,211 | 313 | AstraZeneca Pharmaceuticals LP ($584.17) |
| 2021 | $4,249 | 289 | AbbVie Inc. ($593.67) |
| 2020 | $3,136 | 216 | AstraZeneca Pharmaceuticals LP ($452.30) |
| 2019 | $3,197 | 251 | AstraZeneca Pharmaceuticals LP ($456.77) |
| 2018 | $3,159 | 248 | AstraZeneca Pharmaceuticals LP ($560.83) |
| 2017 | $2,166 | 158 | AstraZeneca Pharmaceuticals LP ($528.24) |
All Payment Transactions
1,963 individual payment records from CMS Open Payments — Page 1 of 79
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $19.24 | General |
| Category: RESPIRATORY | ||||||
| 12/19/2024 | Hologic Sales and Service, LLC | APTIMA (Device), THINPREP 2000 PROCESSOR | Food and Beverage | In-kind items and services | $16.18 | General |
| Category: Diagnostics | ||||||
| 12/18/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $19.28 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/18/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $14.89 | General |
| Category: PAIN | ||||||
| 12/17/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $13.71 | General |
| Category: Cardio-renal | ||||||
| 12/12/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $11.97 | General |
| Category: Inflammation | ||||||
| 12/10/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $11.86 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 12/10/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $9.93 | General |
| Category: RESPIRATORY | ||||||
| 12/04/2024 | SCILEX PHARMACEUTICALS INC. | ZTLido (Drug) | Food and Beverage | In-kind items and services | $16.56 | General |
| Category: Analgesic | ||||||
| 12/03/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $14.36 | General |
| Category: DIABETES | ||||||
| 12/03/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $10.60 | General |
| Category: Cardio-renal | ||||||
| 12/02/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.77 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/25/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.42 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/22/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $22.42 | General |
| Category: Oncology | ||||||
| 11/21/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $14.61 | General |
| Category: RESPIRATORY | ||||||
| 11/20/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $23.19 | General |
| Category: UROLOGY | ||||||
| 11/20/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $15.54 | General |
| Category: Cardio-renal | ||||||
| 11/20/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $10.30 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 11/19/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $20.23 | General |
| Category: PAIN | ||||||
| 11/19/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $8.05 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/14/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $13.49 | General |
| Category: Inflammation | ||||||
| 11/13/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $20.92 | General |
| Category: Diabetes | ||||||
| 11/12/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $10.58 | General |
| Category: RESPIRATORY | ||||||
| 11/11/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.56 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/05/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $12.14 | General |
| Category: Cardio-renal | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 32 | 1,709 | 3,067 | $389,583 | $200,985 |
| 2022 | 32 | 2,046 | 3,754 | $440,554 | $217,041 |
| 2021 | 37 | 2,295 | 4,635 | $482,637 | $256,764 |
| 2020 | 38 | 2,634 | 4,393 | $507,601 | $255,124 |
Total Patients
8,684
Total Services
15,849
Medicare Billing
$929,914
Procedure Codes
139
All Medicare Procedures & Services
139 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 246 | 938 | $167,199 | $80,396 | 48.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 157 | 344 | $46,529 | $22,415 | 48.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 131 | 131 | $21,979 | $17,105 | 77.8% |
| 87637 | Detection test by multiplex amplified probe technique for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (covid-19), influenza virus types a and b, and respiratory syncytial virus | Office | 2023 | 70 | 100 | $15,625 | $13,978 | 89.5% |
| G0181 | Physician or allowed practitioner supervision of a patient receiving medicare-covered services provided by a participating home health agency (patient not present) requiring complex and multidisciplinary care modalities involving regular physician or allow | Office | 2023 | 31 | 167 | $26,351 | $12,831 | 48.7% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 85 | 94 | $8,043 | $6,734 | 83.7% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 81 | 87 | $13,594 | $5,153 | 37.9% |
| 99498 | Advance care planning, each additional 30 minutes | Office | 2023 | 81 | 87 | $13,072 | $4,975 | 38.1% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 26 | 26 | $5,376 | $4,314 | 80.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 48 | 53 | $11,154 | $4,223 | 37.9% |
| 92100 | Multiple measurements of eye fluid pressure over an extended time period | Office | 2023 | 50 | 58 | $8,256 | $3,557 | 43.1% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 86 | 95 | $4,300 | $2,972 | 69.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 26 | 26 | $6,277 | $2,436 | 38.8% |
| G0513 | Prolonged preventive service(s) (beyond the typical service time of the primary procedure), in the office or other outpatient setting requiring direct patient contact beyond the usual service; first 30 minutes (list separately in addition to code for preve | Office | 2023 | 37 | 37 | $4,646 | $2,371 | 51.0% |
| 76700 | Complete ultrasound scan of abdomen | Office | 2023 | 20 | 23 | $4,968 | $2,091 | 42.1% |
| G0179 | Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | Office | 2023 | 22 | 61 | $3,747 | $1,996 | 53.3% |
| 90732 | Pneumococcal vaccine, 23-valent | Office | 2023 | 11 | 11 | $2,038 | $1,439 | 70.6% |
| G0446 | Annual, face-to-face intensive behavioral therapy for cardiovascular disease, individual, 15 minutes | Office | 2023 | 54 | 54 | $2,047 | $1,418 | 69.3% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 73 | 73 | $1,907 | $1,361 | 71.4% |
| 96375 | Injection of additional new drug or substance into vein | Office | 2023 | 20 | 87 | $2,937 | $1,051 | 35.8% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 26 | 27 | $2,143 | $1,042 | 48.6% |
| 82274 | Stool analysis for blood, by fecal hemoglobin determination by immunoassay | Office | 2023 | 55 | 59 | $1,077 | $920.40 | 85.5% |
| 96361 | Infusion into a vein for hydration, each additional hour | Office | 2023 | 20 | 87 | $2,003 | $804.18 | 40.2% |
| 96374 | Injection of drug or substance into vein | Office | 2023 | 20 | 29 | $2,432 | $795.05 | 32.7% |
| 87880 | Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | Office | 2023 | 36 | 47 | $940.00 | $761.40 | 81.0% |
About Dr. Duc Phan, M.D
Dr. Duc Phan, M.D is a Internal Medicine healthcare provider based in Houston, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/06/2010. The National Provider Identifier (NPI) number assigned to this provider is 1083946693.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Duc Phan, M.D has received a total of $27,171 in payments from pharmaceutical and medical device companies, with $3,124 received in 2024. These payments were reported across 1,963 transactions from 65 companies. The most common payment nature is "Food and Beverage" ($26,762).
As a Medicare-enrolled provider, Phan has provided services to 8,684 Medicare beneficiaries, totaling 15,849 services with total Medicare billing of $929,914. Data is available for 4 years (2020–2023), covering 139 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Internal Medicine
- Location Houston, TX
- Active Since 02/06/2010
- Last Updated 12/06/2013
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1083946693
Products in Payments
- FARXIGA (Drug) $2,784
- Ozempic (Drug) $988.86
- LINZESS (Drug) $907.38
- Vascepa (Drug) $888.03
- Kerendia (Drug) $850.82
- TRELEGY ELLIPTA (Drug) $805.43
- ZENPEP (Drug) $715.15
- Otezla (Drug) $704.54
- MOUNJARO (Drug) $673.72
- JARDIANCE (Drug) $650.48
- ZTLido (Drug) $631.11
- UBRELVY (Drug) $580.18
- BREZTRI (Drug) $580.08
- XIFAXAN (Drug) $577.53
- NURTEC ODT (Drug) $533.41
- VRAYLAR (Drug) $514.81
- TRULICITY (Drug) $510.63
- LYRICA (Drug) $406.74
- XARELTO (Drug) $380.29
- GEMTESA (Drug) $379.00
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Houston
Stephen Pappas, M.d, M.D
Internal Medicine — Payments: $1.6M
Internal Medicine $1.6M
Mohamed Othman, Md, MD
Internal Medicine — Payments: $1.1M
Internal Medicine $1.1M
Dr. Aung Naing, Md, MD
Internal Medicine — Payments: $925,146
Internal Medicine $925,146
Miguel Escobar, M.d, M.D
Internal Medicine — Payments: $924,228
Internal Medicine $924,228
Dr. Christie Ballantyne, Md, MD
Internal Medicine — Payments: $815,154
Internal Medicine $815,154
John Heymach, M.d, M.D
Internal Medicine — Payments: $786,947
Internal Medicine $786,947